Response to Immunotherapy in Combination With Mitotane in Patients With Metastatic Adrenocortical Cancer

Adrenocortical carcinoma (ACC) is a rare orphan disease with a dismal prognosis. Surgery remains the first-line treatment, but most patients eventually develop metastatic disease. Mitotane is often used with chemotherapy with modest success. Little information is available concerning the efficacy of...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Endocr Soc
Main Authors: Head, Lia, Kiseljak-Vassiliades, Katja, Clark, Toshimasa J, Somerset, Hilary, King, Jonathan, Raeburn, Christopher, Albuja-Cruz, Maria, Weyant, Michael, Cleveland, Joseph, Wierman, Margaret E, Leong, Stephen
Format: Artigo
Jezik:Inglês
Izdano: Endocrine Society 2019
Teme:
Case Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6853671/
https://ncbi.nlm.nih.gov/pubmed/31745526
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-00305
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki